Indeed, in a tumor mouse model, the combined administration of pulsed pDCs and cDC2s with OVA increased the amounts of OVA-specific CD8 T-cells compared to immunization with only one of the two subtypes of DCs [164]. Here, CD8A is linked to neoplasm.